In March 2025, the company declared new options for just a direct-to-consumer giving of its Wegovy weight loss drug. The company recognized a different pharmacy, referred to as NovoCare, which would cost shoppers $499 per month for access to the drug, below fifty percent the cost of the drug by other pharmaceutical distribution networks.[53]Knowing